Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
出版年份 2021 全文链接
标题
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
作者
关键词
-
出版物
Science Advances
Volume 7, Issue 36, Pages -
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-09-04
DOI
10.1126/sciadv.abj5365
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
- (2021) Philip J.M. Brouwer et al. CELL
- A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
- (2021) Vincent Legros et al. Cellular & Molecular Immunology
- Neutralizing antibody titres in SARS-CoV-2 infections
- (2021) Eric H. Y. Lau et al. Nature Communications
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
- (2021) Piyada Supasa et al. CELL
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- (2021) Wilfredo F. Garcia-Beltran et al. CELL
- SARS-CoV-2 spike D614G change enhances replication and transmission
- (2021) Bin Zhou et al. NATURE
- Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
- (2021) Dami A. Collier et al. NATURE
- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
- (2021) Nicholas G. Davies et al. SCIENCE
- Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
- (2021) Alexander Muik et al. SCIENCE
- The effect of spike mutations on SARS-CoV-2 neutralization
- (2021) Chloe Rees-Spear et al. Cell Reports
- Prolonged evolution of the human B cell response to SARS-CoV-2 infection
- (2021) Mrunal Sakharkar et al. Science Immunology
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough
- (2021) Rita Rubin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pandemic moves and countermoves: vaccines and viral variants
- (2021) Rogier W Sanders et al. LANCET
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine Breakthrough Infections with SARS-CoV-2 Variants
- (2021) Ezgi Hacisuleyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
- (2021) Leonidas Stamatatos et al. SCIENCE
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
- (2020) Fabian Schmidt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections
- (2020) Ger Rijkers et al. JOURNAL OF INFECTIOUS DISEASES
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
- (2020) Lakshmanane Premkumar et al. Science Immunology
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
- (2020) Christopher O. Barnes et al. NATURE
- Validation and clinical evaluation of a SARS-CoV-2 Surrogate Virus Neutralisation Test (sVNT)
- (2020) Benjamin Meyer et al. Emerging Microbes & Infections
- Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
- (2020) Alexandra Schäfer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
- (2017) Jesper Pallesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started